Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Metastasis02:30

Metastasis

7.0K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
7.0K
Proteomics01:33

Proteomics

10.2K
A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...
10.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Intensity-modulated radiotherapy/Volumetric modulated Arc therapy including four Brachytherapy fractions versus 3D conformal radiotherapy containing five Brachytherapy fractions in the treatment of cervical cancer.

Radiation oncology (London, England)·2026
Same author

Paving the Way for CCK2R-Targeted Peptide Receptor Radionuclide Therapy with [<sup>177</sup>Lu]Lu-DOTA-MGS5 in Patients with Small Cell Lung Cancer.

Pharmaceutics·2026
Same author

Biopsy-proven residual cervical cancer at the end of combined chemoradiation predicts poor outcome-Retrospective single-center cohort study.

Acta obstetricia et gynecologica Scandinavica·2025
Same author

Changes in spatial bodily pain distribution one year after benign hysterectomy with emphasis on prevalence and risk factors for de novo and persistent pelvic pain- a prospective longitudinal multicenter study.

BMC women's health·2024
Same author

Iron(III)-salophene catalyzes redox cycles that induce phospholipid peroxidation and deplete cancer cells of ferroptosis-protecting cofactors.

Redox biology·2024
Same author

Prognosis versus Actual Outcomes in Stereotactic Radiosurgery of Brain Metastases: Reliability of Common Prognostic Parameters and Indices.

Current oncology (Toronto, Ont.)·2024

Related Experiment Video

Updated: Apr 14, 2026

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

3.0K

Proteomic approach to understand metastatic spread.

Sergej Skvortsov1, Christoph R Arnold1, Paul Debbage2

  • 1Laboratory for Experimental and Translational Research on Radiation Oncology (EXTRO-Lab), Department of Therapeutic Radiology and Oncology, Innsbruck Medical University, Innsbruck, Austria.

Proteomics. Clinical Applications
|April 28, 2015
PubMed
Summary

Metastasis, a major cause of cancer death, requires understanding its molecular drivers. Proteomic analysis of metastatic cells offers a promising strategy for identifying therapeutic targets and biomarkers for cancer spreading.

Keywords:
BiomarkerCancerMetastasisTarget

More Related Videos

Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors
08:08

Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors

Published on: February 27, 2015

17.1K
An Orthotopic Murine Model of Human Prostate Cancer Metastasis
06:48

An Orthotopic Murine Model of Human Prostate Cancer Metastasis

Published on: September 18, 2013

36.2K

Related Experiment Videos

Last Updated: Apr 14, 2026

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

3.0K
Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors
08:08

Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors

Published on: February 27, 2015

17.1K
An Orthotopic Murine Model of Human Prostate Cancer Metastasis
06:48

An Orthotopic Murine Model of Human Prostate Cancer Metastasis

Published on: September 18, 2013

36.2K

Area of Science:

  • Oncology
  • Molecular Biology
  • Proteomics

Background:

  • Metastasis is the primary cause of cancer-related mortality.
  • Current understanding of the molecular mechanisms driving tumor cell dissemination and survival is limited.
  • Identifying molecular characteristics of metastatic cells is crucial for developing targeted therapies and biomarkers.

Purpose of the Study:

  • To review the potential of proteomic approaches in analyzing metastasis-specific protein patterns.
  • To highlight the importance of cell phenotype over genotype in understanding metastasis.
  • To discuss the utility of proteomic analysis across various sample types for cancer research.

Main Methods:

  • Review of existing literature on proteomic strategies for metastasis research.
  • Discussion of analyzing protein expression in different cancer models (in vitro, in vivo).
  • Exploration of proteomic analysis in patient-derived samples (tissues, biological fluids).

Main Results:

  • Proteomics can reveal metastasis-specific protein signatures.
  • Phenotypic characteristics of metastatic cells are key targets for investigation.
  • Analysis across diverse sample types provides a comprehensive view of metastatic processes.

Conclusions:

  • Proteomic approaches are valuable tools for dissecting the molecular underpinnings of cancer metastasis.
  • Identifying metastasis-associated proteins can lead to novel biomarkers and therapeutic strategies.
  • Understanding the proteomic landscape of metastatic cells is essential for combating cancer spread.